Document is current
Any future updates will be listed below
-
Authors
Miki, Kenji https://orcid.org/0000-0001-7901-6133
Deguchi, Kohei
Nakanishi-Koakutsu, Misato
Lucena-Cacace, Antonio https://orcid.org/0000-0002-1181-2683
Kondo, Shigeru
Fujiwara, Yuya
Hatani, Takeshi https://orcid.org/0000-0002-4204-2706
Sasaki, Masako
Naka, Yuki
Okubo, Chikako https://orcid.org/0000-0001-5562-410X
Narita, Megumi https://orcid.org/0000-0002-8198-4042
Takei, Ikue
Napier, Stephanie C. https://orcid.org/0000-0001-9611-566X
Sugo, Tsukasa
Imaichi, Sachiko
Monjo, Taku
Ando, Tatsuya
Tamura, Norihisa
Imahashi, Kenichi
Nishimoto, Tomoyuki
Yoshida, Yoshinori https://orcid.org/0000-0001-5511-9090
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (18K15120, 18KK0461, 17H04176)
Japan Agency for Medical Research and Development (19bm0104001h0007, 19bm0204003h0107, 19bm0804008h0103, 20bm0804022h0001, 19bk0104095h0001)
Fondation Leducq (18CVD05)
a grant from Takeda Pharmaceutical Company Limited SECOM Science and Technology Foundation
- License Information
-
More Information
Article History
Received: 1 November 2019
Accepted: 17 May 2021
First Online: 21 June 2021
Competing interests
: Y.Y. received research expense from Takeda Pharmaceutical Company, Ltd, and K.D., S.K., S.C.N., S.I, T.M., T.A., N.T., K.I., T.N. are employees of Takeda Pharmaceutical Company, Ltd. K.M., S.K., and Y.Y. are the inventors of the patent application (WO2019/189554). The other authors declare no competing interests.
